FUROQUINOLINEDIONES AS INHIBITORS OF TDP2
US Patent 10,906,914
Filed on 2017-07-10
Filed on 2017-07-10
Furoquinolinedione As Inhibitors Of TDP2
European Patent
16703001.4
Filed on 2016-01-08
16703001.4
Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2
Canada
2973484
Filed on 2016-01-08
2973484
Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2
Australia
2016205137
Filed on 2016-01-08
2016205137
Filed on 2016-01-08
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Australia
2017204103
Filed on 2017-06-16
2017204103
Filed on 2017-06-16
Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same
US Application 15/489,130
Filed on 2017-04-17
Filed on 2017-04-17
Peptide-Based Methods For Treating Pancreatic Cancer
US Patent 10,016,480
Filed on 2017-04-10
Filed on 2017-04-10
Peptide-Based Methods For Treating Pancreatic Cancer
South Korea
10-2017-7012656
Filed on 2017-05-10
10-2017-7012656
Filed on 2017-05-10
Peptide-Based Methods For Treating Pancreatic Cancer
Japan
2017-540549
Filed on 2017-04-14
2017-540549
Filed on 2017-04-14
Peptide-Based Methods For Treating Pancreatic Cancer
European Patent
15788259.8
Filed on 2015-10-13
15788259.8
Filed on 2015-10-13